Vilniaus Degtine AB:企業の戦略・SWOT・財務情報

◆英語タイトル:Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3895
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:リトアニア
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,100見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥46,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥69,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vilniaus Degtine AB – Strategy, SWOT and Corporate Finance Report
Summary

Vilniaus Degtine AB – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vilniaus Degtine AB (Vilniaus Degtine), a subsidiary of Marie Brizard Wine & Spirits, is principally involved in the production and sale of alcoholic beverages in Lithuania and internationally. Its product portfolio includes vodka, bitter, liqueur, brandy, gin, rum, balsam and other related alcoholic drinks. The major brands of the company include Bajorų, Sobieski, Renaissance, Gedimino“,Čepkelių, Starka William Peel, Gautier, Marie Brizard, and Sobieski, to name a few. Vilniaus Degtine also manufactures distilled food grade ethyl alcohol from rye and triticale. It exports products to Latvia, Poland, Estonia, France, Azerbaijan, China, Denmark, Israel, Ukraine, Spain and the US. The company owns a cogeneration power plant for the heat and electricity production. Vilniaus Degtine is headquartered in Vilnius, Lithuania

Scope

- Detailed information on Vilniaus Degtine AB required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vilniaus Degtine AB in the form of a SWOT analysis
- An in-depth view of the business model of Vilniaus Degtine AB including a breakdown and examination of key business segments
- Intelligence on Vilniaus Degtine AB’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vilniaus Degtine AB, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vilniaus Degtine AB and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vilniaus Degtine AB as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vilniaus Degtine AB’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vilniaus Degtine AB: Company Overview 8
Vilniaus Degtine AB: Overview and Key Facts 8
Vilniaus Degtine AB: Overview 8
Vilniaus Degtine AB: Key Facts 8
Vilniaus Degtine AB: Key Employees 10
Vilniaus Degtine AB: Major Products and Services 11
Vilniaus Degtine AB: Company History 12
Vilniaus Degtine AB: Management Statement 13
Vilniaus Degtine AB: Locations and Subsidiaries 14
Vilniaus Degtine AB: Key Competitors 15
Vilniaus Degtine AB: Company Analysis 16
Vilniaus Degtine AB: Business Description 16
Vilniaus Degtine AB: SWOT Analysis 17
Vilniaus Degtine AB: SWOT Overview 17
Vilniaus Degtine AB: Strengths 17
Vilniaus Degtine AB: Weaknesses 18
Vilniaus Degtine AB: Opportunities 18
Vilniaus Degtine AB: Threats 19
Vilniaus Degtine AB: Corporate Financial Deals Activity 20
Vilniaus Degtine AB: Financial Deals Overview 20
Vilniaus Degtine AB: Top Deals 2014 – 2018YTD* 21
Vilniaus Degtine AB: Private Equity and Ownership 22
Vilniaus Degtine AB: Recent Developments 23
Vilniaus Degtine AB: News and Events Summary 23
Vilniaus Degtine AB: Corporate Governance 23
Appendix 25
Contact Us 25
Methodology 25
About MarketLine 26

List of Tables
Table 1: Vilniaus Degtine AB: Key Facts
Table 2: Vilniaus Degtine AB: Key Employees
Table 3: Vilniaus Degtine AB: Locations and Subsidiaries
Table 4: Vilniaus Degtine AB: Key Competitors
Table 5: Vilniaus Degtine AB: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Vilniaus Degtine AB: Top Deals 2014 - 2018YTD*
Table 7: Vilniaus Degtine AB: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 8: Vilniaus Degtine AB: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 9: Vilniaus Degtine AB: News and Events Summary
Table 10: Vilniaus Degtine AB: Corporate Governance

List of Figures
Figure 1: Vilniaus Degtine AB: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Vilniaus Degtine AB: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 3: Vilniaus Degtine AB: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Vilniaus Degtine AB:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Acarix AS-医療機器分野:企業M&A・提携分析
    Summary Acarix A/S (Acarix) is a medical device company that offers design and development of non-invasive cardiac screening products. The company offers non-invasive screening device, CADScor system used to record, process and display heart signals as a patient specific score as the CAD-score on th …
  • Scioderm Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scioderm Inc (Scioderm), a subsidiary of Amicus Therapeutics Inc is a clinical stage biopharmaceutical company that develops various therapies. The company develops novel therapies for conditions including orphan diseases. Its product include Zorblisa (SD-101), is developed for treating the …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Exact Sciences Corp (EXAS):企業の製品パイプライン分析2018
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • International Flavors & Fragrances Inc.:戦略・SWOT・企業財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • M3 Inc (2413):企業の財務・戦略的SWOT分析
    M3 Inc (2413) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Tien Phong Plastic (NTP):企業の財務・戦略的SWOT分析
    Tien Phong Plastic (NTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Core-Mark Holding Company, Inc.:企業の戦略・SWOT・財務分析
    Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Vail Resorts Inc:企業の戦略・SWOT・財務情報
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solution …
  • NH Foods Ltd.:企業の戦略・SWOT・財務情報
    NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Axcella Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Axcella Health Inc (Axcella), formerly Pronutria Biosciences Inc is a developer of disease-specific amino acid profiles. The company’s lead clinical-stage candidates AXA are based on cell-specific sets of amino acids that regulate multiple biological pathways. Its amino acid therapies helps …
  • Intelsat S.A. (I):企業の財務・戦略的SWOT分析
    Intelsat S.A. (I) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Carestream Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Carestream Health Inc (Carestream) a subsidiary of Onex Corp, provides dental and medical imaging systems and healthcare IT solutions. It also offers X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets. Care …
  • Whataburger Restaurants LP:戦略・SWOT・企業財務分析
    Whataburger Restaurants LP - Strategy, SWOT and Corporate Finance Report Summary Whataburger Restaurants LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Invenergy LLC:企業の戦略的SWOT分析
    Invenergy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Tgb Banquets And Hotels:企業の戦略・SWOT・財務分析
    Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report Summary Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆